IPO - BIO KEY INTERNATIONAL INC

Form Type: CORRESP

Filing Date: 2025-05-02

Corporate Action: Ipo

Type: New

Accession Number: 000143774925014332

Filing Summary: BIO-key International, Inc. has submitted a request for acceleration of the effective date of its Registration Statement on Form S-1, with Commission File No. 333-286776. The requested effective date is set for 4:00 pm EST on May 5, 2025, or as soon thereafter as practicable. This acceleration is in accordance with Rule 461 of the Securities Act of 1933, as amended. The correspondence is addressed to the U.S. Securities and Exchange Commission.

Form Type: S-1

Filing Date: 2025-04-25

Corporate Action: Ipo

Type: New

Accession Number: 000143774925013165

Filing Summary: BIO-key International, Inc. filed a registration statement on Form S-1 with the SEC to register up to 3,091,668 shares of common stock for resale by a selling stockholder. This includes shares issuable upon the exercise of Series A and Series B warrants. The registration is part of BIO-key's strategy to list their common stock on the Nasdaq Capital Market under the symbol 'BKYI'. The offering aims to commence as soon as practicable following effectiveness and will not bring proceeds to the company, as all proceeds will go to the selling stockholder. The document outlines the company's operations in identity and access management, showcasing its product offerings such as PortalGuard and WEB-key. It emphasizes the importance of securing access for enterprise and government clients, while also highlighting the company's strategic focus on growth through acquisitions and expanding market share in regulated sectors like healthcare and education. It covers risks associated with the investment, including market liquidity and potential dilution of shares, as well as the company's marketing and sales strategies.